Equity - Narrative (Details) - USD ($)	3 Months Ended	9 Months Ended
	Sep. 30, 2023	Sep. 30, 2023	Sep. 30, 2022	Dec. 31, 2022
Class of Stock [Line Items]
Common stock, shares authorized (in shares)	280,000,000	280,000,000		280,000,000
Preferred stock, shares authorized (in shares)	50,000,000	50,000,000		50,000,000
Common stock issued in connection with stock options exercised (in shares)		5,773
Common stock issued through the dividend reinvestment plan (in shares)		2,577	2,057
Forward contract indexed to issuer's equity (in shares)		2,000,000
Common stock issued through Employee Stock Purchase Plan (in shares)		12,288
Number of shares of stock grants withheld (in shares)		62,482	72,132
Repurchases of shares (in shares)		11,800
Net proceeds of forward contract indexed to issuer's equity		$ 491,912,000
Forward contract indexed to equity, settlement fair value (in dollars per share)	$ 245.96	$ 245.96
Treasury stock acquired (in dollars per share)		$ 161.96
Stock repurchase program, remaining authorized amount	$ 314,237,000	$ 314,237,000
2020 Stock Repurchase Program
Class of Stock [Line Items]
Stock repurchase program, authorized amount	500,000,000	500,000,000
Continuous Equity Program CEP V
Class of Stock [Line Items]
Maximum value of shares of common stock that can be sold (in dollars)	$ 1,000,000,000	$ 1,000,000,000
Common stock sold under CEP V (in shares)	0	0
Common stock value, remaining to be authorized under continuous equity program	$ 705,961,000	$ 705,961,000
Restricted Stock and Common Stock Converted from Performance Shares
Class of Stock [Line Items]
Equity instruments granted (in shares)		152,894	136,115
Restricted stock
Class of Stock [Line Items]
Equity instruments granted (in shares)		92,878	82,062
Stock issued during period, shares, share-based compensation, forfeited (in shares)		2,119	3,235